Ecallantide: An alternative treatment of refractory angioedema in adolescents with systemic lupus erythematosus

J Allergy Clin Immunol Pract. 2020 Mar;8(3):1115-1116. doi: 10.1016/j.jaip.2019.08.052. Epub 2019 Sep 18.
No abstract available

MeSH terms

  • Adolescent
  • Angioedema* / drug therapy
  • Humans
  • Lupus Erythematosus, Systemic* / complications
  • Lupus Erythematosus, Systemic* / drug therapy
  • Peptides

Substances

  • Peptides
  • ecallantide